<p>BMDM were incubated overnight with DMSO or 200 µM MTA in the absence or presence of the following TLR ligands: 10 ng/mL LPS, 10 µg/mL polyI:C, 1 µg/mL Pam3CSK4, 6.67 µM CpG or 2 µg/mL Imiquimod. Supernatants were assayed for TNFα (A), IL-6 (B) or IL-10 (C) production by ELISA while cells were harvested, stained and analyzed for surface CD69 (D,E) or CD86 (D, F) expression by FACS. Graphs represent mean ±sem of 3 (A, E, F), 4 (C) or 5 (B) experiments. * p<0.05, ** p<0.01, *** p<0.001.</p
MDM were treated with antibodies against TNFR1 or TNFR2 prior to infection. After 24 h of infection,...
<p>(A) TNF-α, IL-6 and MCP-1 concentration on day 3 by ELISA (n = 6 per group). (B, C) HMGB1 (B) and...
<p>(a) Average rolling velocity (left) and average number of MDA-MB-231 cells interacting with E-sel...
<p>BMDM were incubated overnight with DMSO, the indicated concentrations of MTA or adenosine (Ado), ...
<p>(A) BMDM were incubated for 4 h with either DMSO or 200 µM MTA in the absence or presence of eith...
<p>BMDM were treated overnight with either 0 ng/mL, 10 ng/mL, or 100 ng/mL (A–C) or 100 EU/mL (D) LP...
<p>BMDM were primed for 4 h with 10 ng/mL LPS in the absence or presence of 200 µM or 500 µM MTA, th...
<p>Intracellular Ki-67 expression (3A, 3C) and cell surface CD69 (3B, 3D) were analyzed after 7 days...
<p>Peritoneal macrophages were treated with the indicated concentrations of compound <b>1</b> (2.5, ...
<p>(A) MBL binds to PMA-activated THP-1 cells in a Ca<sup>2+</sup>-dependent manner. PMA-activated T...
<p>(<b>A</b>) MDMs were treated with TLR2 agonist (Pam3CSK4, 1 µg/ml), TLR4 agonist (MPLA, 1 µg/ml) ...
<p>Splenic γδ T cells of MyD88<sup>−/−</sup> (<i>A</i>–<i>D</i>) or TLR7<sup>−/−</sup> mice (<i>E</i...
<p>(<b>A, B</b>) B cells were incubated with anti-mouse TLR2 blocking antibody (100 ng/ml) or isotyp...
<p>(A,B) BMDMs were pre-treated with A-769662 (100, 250 or 500 μM) for 2 hours before stimulated wit...
<p>gmMφ and mMφ were stimulated with ICs (50 µg/ml) (<b>A</b>), LPS (100 ng/ml) or LPS+ICs (<b>B</b>...
MDM were treated with antibodies against TNFR1 or TNFR2 prior to infection. After 24 h of infection,...
<p>(A) TNF-α, IL-6 and MCP-1 concentration on day 3 by ELISA (n = 6 per group). (B, C) HMGB1 (B) and...
<p>(a) Average rolling velocity (left) and average number of MDA-MB-231 cells interacting with E-sel...
<p>BMDM were incubated overnight with DMSO, the indicated concentrations of MTA or adenosine (Ado), ...
<p>(A) BMDM were incubated for 4 h with either DMSO or 200 µM MTA in the absence or presence of eith...
<p>BMDM were treated overnight with either 0 ng/mL, 10 ng/mL, or 100 ng/mL (A–C) or 100 EU/mL (D) LP...
<p>BMDM were primed for 4 h with 10 ng/mL LPS in the absence or presence of 200 µM or 500 µM MTA, th...
<p>Intracellular Ki-67 expression (3A, 3C) and cell surface CD69 (3B, 3D) were analyzed after 7 days...
<p>Peritoneal macrophages were treated with the indicated concentrations of compound <b>1</b> (2.5, ...
<p>(A) MBL binds to PMA-activated THP-1 cells in a Ca<sup>2+</sup>-dependent manner. PMA-activated T...
<p>(<b>A</b>) MDMs were treated with TLR2 agonist (Pam3CSK4, 1 µg/ml), TLR4 agonist (MPLA, 1 µg/ml) ...
<p>Splenic γδ T cells of MyD88<sup>−/−</sup> (<i>A</i>–<i>D</i>) or TLR7<sup>−/−</sup> mice (<i>E</i...
<p>(<b>A, B</b>) B cells were incubated with anti-mouse TLR2 blocking antibody (100 ng/ml) or isotyp...
<p>(A,B) BMDMs were pre-treated with A-769662 (100, 250 or 500 μM) for 2 hours before stimulated wit...
<p>gmMφ and mMφ were stimulated with ICs (50 µg/ml) (<b>A</b>), LPS (100 ng/ml) or LPS+ICs (<b>B</b>...
MDM were treated with antibodies against TNFR1 or TNFR2 prior to infection. After 24 h of infection,...
<p>(A) TNF-α, IL-6 and MCP-1 concentration on day 3 by ELISA (n = 6 per group). (B, C) HMGB1 (B) and...
<p>(a) Average rolling velocity (left) and average number of MDA-MB-231 cells interacting with E-sel...